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Abstract. The discovery of new anesthetics, more effective and less toxic, gave veterinarians 
the possibility to successfully intervene in resolving the most different situations encountered in their 
activity. 
This study consisted in monitoring respiratory frequency, cardiac frequency and body 
temperature in patients anesthetized and then subdued to different surgical interventions. 
The researches were carried on 20 dogs of different breeds, ages and sexes, diagnosed with 
different types of diseases, which needed surgical treatment under the effect of anesthesia. There were 
selected patients in which pain intensity associated with surgical intervention was relatively equal.  
Anesthesia protocols consisted mainly in the association of two substances: xylazine + 
ketamine – in 5 cases; medetomidine + ketamine – in 5 cases; acepromazine + ketamine – in 5 cases; 
propofol – in 5 cases. 
In case of anesthesia induced by xylazine-ketamine combination, it was observed a slight 
tendency to bradycardia, respiratory frequency oscillations and the decrease of body temperature 
(tendency to hypothermia).  
Medetomidine-ketamine association determined cardiac frequency oscillations (without a 
particular tendency), an initial increase of respiratory frequency followed by come-back to normal and 
a slight decrease of body temperature. 
Using acepromazine-ketamine combination, the studied parameters varied under acceptable 
limits during anesthesia. 
Propofol ensured good conditions for surgical interventions, with the observations that the 
anesthetic effect is short and it requires supplementary safety measures in order to avoid the 
appearance of respiratory disorders. 
The selection of anesthetic substances must be done considering patient-related factors, the 
purpose of anesthesia and the available equipments. 
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INTRODUCTION 
 
The discovery of new anesthetics, more effective and less toxic, gave veterinarians the 
possibility to successfully intervene in resolving the most different situations encountered in 
their activity (Muir et al., 1995). 
Due to the “surgical silence” ensured by anesthetic substances, it became possible also 
the elaboration of new surgical techniques. Practice demonstrated that, in general anesthesia 
realized using only one substance, particularly in long interventions, the therapeutic dose is 
quite close to toxic dose. In order to protect internal organs and avoid affecting respiratory 
and cardiac functions, nowadays there are used associations between substances with 
selective-cumulative effects, which realize a less toxic anesthesia.  
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The purpose of this study was the monitoring of vital functions in anesthesia with 
different associations of general injectable anesthetics in dogs.  
 
MATERIALS AND METHODS 
 
The study consisted in monitoring respiratory frequency, cardiac frequency and body 
temperature in patients anesthetized and then subdued to different surgical interventions. 
The researches were carried on 20 dogs of different breeds, ages and sexes, diagnosed 
with different types of diseases, which needed surgical treatment under the effect of 
anesthesia. There were selected patients in which pain intensity associated with surgical 
intervention was relatively equal.  
Anesthesia protocols consisted mainly in the association of two substances: 
- xylazine + ketamine – in 5 cases; 
- medetomidine + ketamine – in 5 cases; 
- acepromazine + ketamine – in 5 cases; 
- propofol – in 5 cases. 
Xylazine was used as commercial product Xilazina 2%, injectable solution that 
contains xylazine hydrochloride 2 g/100 ml, in dose of 3 mg/kg body weight intramuscularly 
(0.15 ml sol/kg b.w.) or 1 mg/kg b.w. intravenously (0.05 ml sol/kg b.w.). 
Medetomidine was used as Domitor commercial product, injectable solution that 
contains medetomidine hydrochloride 1 mg/ml (0.1%), in dose of 750 mcg/m2 body surface 
(0.75 ml sol/m2) intravenously or 1000 mcg/m2 body surface (1 ml sol/m2) intramuscularly. 
As for dosage per kg body weight, medetomidine was administered in a dose of 20 mcg/kg 
b.w. (0.02 ml sol/kg b.w.) intravenously. 
Acepromazine was used as Neurotranq commercial product, injectable solution that 
contains acepromazine maleate 1 g/100 ml solution (1%), in dose of 0.2-0.3 mg/kg b.w. (0.02-
0.03 ml/kg b.w.), intravenously or intramuscularly. 
Propofol was used as Recofol 1% commercial product, emulsion that contains 10 
mg/ml solution, in dose of 6 mg/kg b.w., strictly intravenously. The protocol included initially 
the administration of 25% of total calculated dose, and then at every 30 seconds it was 
administered 25% of the rest of the quantity. Propofol was used as anesthetic in situations that 
required short time anesthesia (maximum 15 minutes). 
Ketamine was used as two commercial products: Vetased 10% (100 mg/ml solution) 
and Ketamine 10% (100 mg/ml solution), in dose of 6 mg/kg b.w. (0.06 ml/kg b.w.) 
intravenously or 10 mg/kg b.w. (0.1 ml/kg b.w.) intramuscularly. 
Before anesthesia, it was applied premedication with atropine in order to reduce 
digestive and respiratory secretions and to avoid vomiting during surgical interventions; 
atropine was administered in dose of 1-5 mg/dog (0.1-0.5 ml sol 1%). Also, all investigated 
dogs were subdued to alimentary restriction for 6 hours before the anesthesia (Diaconescu, 
2003). 
The investigated parameters (respiratory frequency, cardiac frequency and body 
temperature) were monitored both before anesthesia and during anesthesia. 
 
 
RESULTS AND DISCUSSIONS 
 
Following the researches, the results are presented in Tab. 1.  
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Tab. 1 
The variation of respiratory frequency, cardiac frequency and body temperature in dogs anesthetized with 
different injectable substances   
 
Respiratory 
frequency (nr./min) 
Cardiac frequency 
(nr./min) 
Body temperature 
(°C) 
Parameter  
 
 
Substance  
The moment, 
depending on T0 = 
anesthesia  
moment Range  Average Range  Average Range  Average 
0 9-19 14 90-105 98 38.3-39.2 38.6 
+5’ 9-14 12 90-98 93 38.0-38.7 38.3 
+15’ 10-16 13 74-90 86 38.0-38.8 38.3 
+30’ 14-17 16 72-80 75 37.7-38.2 37.9 
+45’ 14-22 17 74-83 80 37.5-38.0 37.7 
+60’ 11-15 14 67-85 79 37.3-37.7 37.5 
Xylazine + 
ketamine 
+90’ 10-18 13 65-96 82 36.9-37.5 37.3 
0 16-18 17 104-114 108 38.6-39.0 38.9 
+5’ 21-23 22 126-148 134 38.5-39.1 38.8 
+15’ 18-20 19 121-129 123 38.2-38.7 38.4 
+30’ 15-17 16 114-119 116 38.1-38.5 38.2 
+45’ 15-17 16 108-112 111 38.0-38.3 38.1 
Medetomidine + 
ketamine 
+60’ 15-17 16 104-110 107 38.0-38.3 38.1 
0 14-23 17 90-99 94 38.6-39.2 38.8 
+5’ 12-16 14 100-119 110 38.5-39.0 38.8 
+15’ 11-14 12 102-126 118 38,5-39.0 38.7 
+30’ 14-18 16 104-115 108 38.5-38.9 38.6 
+45’ 15-18 17 101-107 106 38.2-38.7 38.4 
Acepromazine + 
ketamine 
+60’ 15-19 18 100-109 104 38.0-38.6 38.2 
0 12-21 16 82-112 96 38.5-38.9 38.7 
+5’ 12-17 15 84-116 99 38.6-38.9 38.7 Propofol  
+15’ 11-19 14 85-117 102 38.6-38.7 38.6 
 
The variation of the three studied parameters was different depending on the 
substance. In case of xylazine-ketamine association, respiratory frequency was quite variable 
(12-17/min), similar with the one recorded in case of acepromazine-ketamine association (12-
17/min). As for medetomidine-ketamine association, it was recorded a slight tendency to 
tachypnea (16-22/min) (Fig.1). Propofol ensured constant values of respiratory frequency (14-
16/min); in spite of that, some studies quote cases in which propofol can induce respiratory 
depression and even apnea (Cristea, 2005; Matthews et al., 2004; Sano et al., 2003; Tanaka et 
al., 1998). In order to avoid these aspects, propofol was injected gradually and slowly. 
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Fig. 1. The variation of respiratory frequency in dogs anesthetized with different injectable substances   
 
 
Cardiac frequency oscillated in quite wide limits: in case of xylazine-ketamine 
combination, average cardiac frequency ranged between 75-98 heart beats/min, in case of 
acepromazine-ketamine association between 94-118 beats/min, in case of medetomidine-
ketamine between 107-134 beats/min (slight tendency to tachycardia) and in case of  propofol 
between 96-102 heart beats/min (Fig. 2).  
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Fig. 2. The variation of cardiac frequency in dogs anesthetized with different injectable substances   
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It is well known that body temperature decreases during anesthesia. From Fig. 3 it can 
be observed that propofol determined the lowest decrease of body temperature, probably due 
to the fact that anesthesia was very short (maximum 15 minutes). The highest variations of 
body temperature were recorded in case of xylazine-ketamine association (38.6-37.3°C), in 
this situation being observed also the lowest value of body temperature (37.3°C). 
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Fig. 3. The variation of body temperature in dogs anesthetized with different injectable substances   
 
Following the researches, from all the used anesthetics it was considered that xylazine-
ketamine combination determines important modifications of the studied parameters. 
 
 
CONCLUSIONS 
 
In case of anesthesia induced by xylazine-ketamine combination, it was observed a 
slight tendency to bradycardia, respiratory frequency oscillations and the decrease of body 
temperature (tendency to hypothermia).  
Medetomidine-ketamine association determined cardiac frequency oscillations 
(without a particular tendency), an initial increase of respiratory frequency followed by 
come-back to normal and a slight decrease of body temperature. 
Using acepromazine-ketamine combination, the studied parameters varied under 
acceptable limits during anesthesia. 
Propofol ensured good conditions for surgical interventions, with the observations that 
the anesthetic effect is short and it requires supplementary safety measures in order to 
avoid the appearance of respiratory disorders. 
The selection of anesthetic substances must be done considering patient-related 
factors, the purpose of anesthesia and the available equipments. 
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